The table below shows Tyra Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$32.57M
-$25.46M
-$22.03M
-$9.85M
-$8.93M
-$4.68M
Capital expenditure
$88.00K
$14.00K
$136.00K
$41.00K
$239.00K
$60.00K
Investing cash flow
-$120.24M
$32.03M
$18.07M
-$41.00K
-$239.00K
-$60.00K
Dividends paid
-
-
-
TYRA operating cash flow (10-K history)
Tyra Biosciences, Inc. reported operating cash flow of -$95.14M for fiscal year 2025. That is down 36.4% from -$69.77M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$7.76M (FY 2020) to -$95.14M. Figures come from the company's audited annual reports as filed with the SEC.